- Generic name
- Ondansetron
- Strength
- 80 mg/100 ml
- Dosage form
- Solution
- Manufactured by
- Asiatic Laboratories Ltd.
Onlit Oral Solution Solution
About Onlit Oral Solution 80 mg/100 ml
The solution Onlit Oral Solution contains Ondansetron and is made by Asiatic Laboratories Ltd. A doctor decides whether it is suitable for a particular situation.
There are 74 brands of Ondansetron listed in Bangladesh. The lowest listed price is Periset 16 mg Suppository at ৳ 1 per unit.
What is Onlit Oral Solution 80 mg/100 ml?
Onlit Oral Solution is a solution from Asiatic Laboratories Ltd., with the generic name Ondansetron. The solution is fast-acting and is often used when oral medicines are not suitable. It is used to prevent nausea and vomiting caused by cancer chemotherapy, radiotherapy, and surgery. The doctor decides the dose and course.
Uses of Onlit Oral Solution
A doctor decides whether it is suitable for a particular situation. Ask the doctor if you are unsure why this medicine has been prescribed for you or someone in your care. It is an anti-emetic medicine, meaning it works against vomiting. Your doctor will decide if it is suitable for you.
How to use Onlit Oral Solution
Take Onlit Oral Solution exactly as the doctor tells you. Complete the course exactly as prescribed. Do not change the dose or stop early without asking your doctor.
Side effects of Onlit Oral Solution
Common side effects reported with Ondansetron include headache, constipation and diarrhoea, and most are mild or moderate. Rarely, serious allergic reactions, breathing problems, fast heartbeat, chest pain, low potassium levels, and shortness of breath have occurred. Rare reports include allergic-type reactions, breathing difficulty, fast heartbeat, chest pain, low potassium and shortness of breath. Tell your doctor if you notice any side effects.
Safety and precautions
The use of Ondansetron in patients following abdominal surgery or in patients with chemotherapy-induced nausea and vomiting may mask a progressive ileus and/or gastric distension. Ondansetron is not a drug that stimulates gastric or intestinal peristalsis. There are, however, no adequate and well-controlled studies in pregna Ask your doctor first if any of these apply to you.
Frequently asked questions
What does Onlit Oral Solution treat?
A doctor decides whether it is suitable for a particular situation. Ask the doctor if you are unsure why this medicine has been prescribed for you or someone in your care.
How is Onlit Oral Solution used?
Take Onlit Oral Solution exactly as the doctor tells you. Complete the course exactly as prescribed.
What should I watch for while using Onlit Oral Solution?
Common side effects reported with Ondansetron include headache, constipation and diarrhoea, and most are mild or moderate. Rarely, serious allergic reactions, breathing problems, fast heartbeat, chest pain, low potassium levels, and shortness of breath have occurred.
Who should be careful with Onlit Oral Solution?
The use of Ondansetron in patients following abdominal surgery or in patients with chemotherapy-induced nausea and vomiting may mask a progressive ileus and/or gastric distension. Ondansetron is not a drug that stimulates gastric or intestinal peristalsis.
Indications
- Prevention of nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy.
- Prevention and treatment of post-operative nausea and vomiting.
- Prevention of radiotherapy-induced nausea and vomiting.
Pharmacology
Dosage & Administration
Adults, Pediatric patients (6 months to 18 years):
- 8 mg tablet/orodispersible tablet: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose.
- 4 mg orodispersible tablet: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose.
- Injection: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose, infused intravenously over 15 minutes.
Adults:
- 8 mg tablet/orodispersible tablet: Initial Dose: 8 mg orally 1 to 2 hours before radiotherapy. Post Radiotherapy: 8 mg orally every 8 hours for up to 5 days after a course of treatment.
- 4 mg orodispersible tablet: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose.
- Injection: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose, infused intravenously over 15 minutes.
Adults:
- 8 mg tablet/orodispersible tablet: 16 mg given as two 8 mg tablets
- 4 mg orodispersible tablet: 16 mg
- Injection: 4 mg
Pediatrics (40 kg): Injection: 0.1 mg/kg
Chemotherapy-induced Nausea and Vomiting-
Adults/Geriatric/Child of 12 years or over:
- Highly emetogenic cancer chemotherapy: 30 ml (24 mg) Ondansetron Oral Solution administered 30 minutes before start of emetogenic chemotherapy.
- Moderate emetogenic cancer chemotherapy: 10 ml (8 mg) Ondansetron Oral Solution administered 30 minutes before start of emetogenic chemotherapy. A further 10 ml dose should be administered after 8 hours of the first dose. One 10 ml dose should be administered twice a day (every 12 hours) for 1-2 days after completion of chemotherapy.
Oral solution:
Radiotherapy induced Nausea and Vomiting (Adults/Geriatric/Child of 12 years or over):- The recommended oral dosage: 10 ml (8 mg) Ondansetron Oral Solution 3 times daily.
- For total body irradiation: 10 ml (8-mg) Ondansetron Oral Solution should be administered 1 to 2 hours before each fraction of radiotherapy administered each day.
- For single high-dose fraction radiotherapy to the abdomen: one 10 ml Ondansetron Oral Solution should be administered 1 to 2 hours before radiotherapy, with subsequent doses every 8 hours after the first dose for 1 to 2 days after completion of radiotherapy.
- For daily fractionated radiotherapy to the abdomen: 10 ml (8-mg) Ondansetron Oral Solution should be administered 1 to 2 hours before radiotherapy, with subsequent doses every 8 hours after the first dose for each day radiotherapy is given.
- 20 ml (16 mg) Ondansetron Oral Solution 1 hour before induction of anesthesia
Oral Soluble Film:
Prevention of nausea and vomiting associated with highly emetogenic cancer chemotherapy:- Adult oral dose: 24 mg given successively as three 8 mg films 30 minutes before the start of chemotherapy.
- Adults and pediatric patients 12 years of age and older: One 8 mg film 30 minutes before chemotherapy followed by an 8 mg dose 8 hours later. Administer one 8 mg film twice a day (every 12 hours) for 1 to 2 days after completion of chemotherapy.
- Pediatric patients 4 through 11 years of age: One 4 mg film three times a day. Administer the first dose 30 minutes before chemotherapy, with subsequent doses 4 and 8 hours later. Administer one 4 mg film three times a day (every 8 hours) for 1 to 2 days after completion of chemotherapy.
- Prevention of nausea and vomiting associated with radiotherapy: The adult dosage is one 8 mg film three times a day.
- Postoperative nausea and vomiting: The adult dose is 16 mg given successively as two 8 mg films 1 hour before anesthesia.
Interaction
Contraindications
Side Effects
Pregnancy & Lactation
Reproduction studies have been performed in pregnant rats and rabbits at daily oral doses up to 15 and 30 mg/kg per day, respectively, and have revealed no evidence of impaired fertility or harm to the fetus due to Ondansetron. There are, however, no adequate and well-controlled studies in pregnant women. Ondansetron is excreted in the breast milk of rats. So caution should be exercised when Ondansetron is administered to a nursing women.
Precautions & Warnings
Storage Conditions
Alternative brands of Ondansetron
Other brands with the same generic name, cheapest first.
Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.